Home |
Free Dividend Report |
Stock Splits Calendar |
SCYX Historical Stock Prices |
Preferred Stock Newsletter |
SCYX Options Chain |
SCYX Message Board |
SCYNEXIS (SCYX) has the following price history information. Looking back at SCYX historical stock prices for the last five trading days, on April 17, 2024, SCYX opened at $1.40, traded as high as $1.46 and as low as $1.37, and closed at $1.42. Trading volume was a total of 127.40K shares. On April 18, 2024, SCYX opened at $1.43, traded as high as $1.48 and as low as $1.39, and closed at $1.41. Trading volume was a total of 79.90K shares. On April 19, 2024, SCYX opened at $1.41, traded as high as $1.47 and as low as $1.39, and closed at $1.44. Trading volume was a total of 131.00K shares. On April 22, 2024, SCYX opened at $1.45, traded as high as $1.48 and as low as $1.44, and closed at $1.44. Trading volume was a total of 72.60K shares. On April 23, 2024, SCYX opened at $1.48, traded as high as $1.61 and as low as $1.48, and closed at $1.55. Trading volume was a total of 151.70K shares.
SCYX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into SCYNEXIS shares, starting with a $10,000 purchase of SCYX, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 05/06/2014 | |
End date: | 04/23/2024 | |
Start price/share: | $84.00 | |
End price/share: | $1.55 | |
Dividends collected/share: | $0.00 | |
Total return: | -98.15% | |
Average Annual Total Return: | -32.99% | |
Starting investment: | $10,000.00 | |
Ending investment: | $184.57 | |
Years: | 9.97 |
SCYX Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/17/2024 | $1.40 | $1.46 | $1.37 | $1.42 | 127.40K |
04/18/2024 | $1.43 | $1.48 | $1.39 | $1.41 | 79.90K |
04/19/2024 | $1.41 | $1.47 | $1.39 | $1.44 | 131.00K |
04/22/2024 | $1.45 | $1.48 | $1.44 | $1.44 | 72.60K |
04/23/2024 | $1.48 | $1.61 | $1.48 | $1.55 | 151.70K |
About SCYNEXIS |
SCYNEXIS is a biotechnology company. Co. is developing its main product candidate, ibrexafungerp, as an intravenous/oral agent for multiple fungal indications in both the community and hospital settings. The U.S. Food and Drug Administration has approved BREXAFEMME (ibrexafungerp tablets) for treatment of patients with vulvovaginal candidiasis, also known as vaginal yeast infection, and for the reduction in the incidence of recurrent vulvovaginal candidiasis, respectively. Co. is also continuing on-going clinical studies of ibrexafungerp for multiple indications, including the treatment of life-threatening invasive fungal infections in hospitalized patients. |
SCYX Historical Closing Prices | |
Date | Close |
04/17/2024 | $1.42 |
04/18/2024 | $1.41 |
04/19/2024 | $1.44 |
04/22/2024 | $1.44 |
04/23/2024 | $1.55 |
Healthcare Historical Prices |
SCYX is categorized under the Healthcare sector; below are some other companies in the same sector:
SDI Historical Stock Prices Also explore: SCYX shares outstanding history
Free SCYX Email Alerts:
|
SCYX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.